The decreased expression of tumour suppressors RASSF1A and DIRAS3 genes—broadly observed in cancerous tissues compared to normal thyroid tissues—proved its involvement in thyroid carcinogenesis. This evidence concerns the gene DIRAS3 and thyroid gland disorder.